Medicine & Life Sciences
Graft vs Host Disease
100%
Allogeneic Cells
43%
Cell Transplantation
34%
Acute Myeloid Leukemia
27%
trans-crotonin
19%
Decitabine
18%
National Institutes of Health (U.S.)
17%
Bronchiolitis Obliterans
17%
GATA2 Deficiency
16%
Stem Cell Transplantation
16%
Tissue Donors
16%
Transplants
16%
Therapeutics
13%
plerixafor octahydrochloride
13%
SARS Virus
13%
Myelodysplastic Syndromes
12%
Survival
12%
INCB018424
11%
PCI 32765
10%
Hematopoietic Stem Cell Mobilization
10%
Transplantation
10%
Consensus
10%
Azacitidine
10%
Hematopoietic Stem Cell Transplantation
8%
Mortality
8%
Leukemia
8%
Biomarkers
8%
Clinical Trials
8%
Steroids
8%
Granulocyte Colony-Stimulating Factor
8%
Stem Cells
8%
Cytomegalovirus
7%
Prednisone
7%
B-Lymphocytes
7%
Familial Acute Myeloid Leukemia with Mutated Cebpa
7%
Bone Marrow
7%
Mutation
7%
montelukast
6%
AIC246
6%
Natural Killer Cells
6%
Fluticasone
6%
Cyclophosphamide
6%
Infections
6%
Confidence Intervals
6%
Germinal Center
6%
ixazomib
6%
Multicenter Studies
6%
Hematopoietic Stem Cells
5%
Azithromycin
5%
Peripheral Blood Stem Cells
5%